CClinicalTrials.gg
CompletedNCT03601377ABMTUpdated Oct 30, 2018

Attention Bias Modification Treatment in Social Anxiety

An interventional study of Training away from threat and Training towards threat in Social Anxiety, sponsored by University of Cyprus. Completed at 1 site in Cyprus. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2018-10-30.

Sponsored by University of Cyprus · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 1 year 8 months after the study started (first participant enrolled Oct 2016, registered Jun 2018).
Phase
Not applicable
Study type
Interventional
Enrollment
140
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This study evaluates attention modification in social anxiety and It is comprised by 2 experiments. At experiment 1 socially anxious participants will receive either training away from threatening faces or placebo intervention and at experiment 2 they will receive either one of these 2 groups or training towards threatening faces. At experiment 2 training will be done under state anxiety levels (video-recording of a speech). Anxiety levels (self-reports, physiological and behavioral measures) as well as attentional biases changes will be examined at pre and post - intervention levels plus 6 months follow-up only for experiment 1.

Read the detailed description

Social anxiety is a highly prevalent disorder in the population. Even though there are effective interventions that can help people who suffer from it, many of them do not seek or receive an evidence-based, face to face treatment. According to cognitive models, attention to social threat is one of the principles that maintain social anxiety. In fact, individuals with social anxiety present attention bias to threat stimuli. However, there is inconsistency in the literature with regards to attentional biases that individuals with anxiety present. A recent model is the vigilance-avoidance hypothesis, in which socially anxious initially focus on the threat and then they avoid it. Therefore, better understanding and then aiming to modify these attentional biases in a computerized manner, with minimal therapist interaction can be a novel and promising way to treat social anxiety, even among patients who avoid presenting for therapy.

Two experiments are aiming to shed some light with regards to the effect of attention bias modification treatment in individuals with social anxiety, taking into consideration the previous mixed results. The first experiment compares training attention to be directed away from threat with a placebo treatment. Approximately 60 socially anxious individuals are randomly allocated in the 2 groups. A structured interview and self-report assessment are done pre-treatment, post-treatment and 6 months follow-up.

The second experiment adds a third group of training towards threat (i.e. exposure), investigating if changing attentional avoidance can also affect anxiety levels. Moreover, the second experiment attempts to improve the typical attention modification paradigm by targeting treatment to participants' identified pre-experimental attentional biases. In addition, predictors of treatment effectiveness will be studied and particularly pre-intervention attentional biases as well as state anxiety. Participants are approximately 90 adults with social phobia who are randomly allocated in treatment and placebo groups. In experiment 2 participants will also be assessed behaviourally as well as physiologically to better demonstrate that anxiety reactions to anxiogenic situations have been reduced between pre and post treatment and that they are smaller than those of a placebo control group.

It is expected that participants in the intervention groups will show reduced attentional bias and social anxiety symptoms in comparison with the placebo group in both studies. In addition, the kind of pre-intervention bias as well as state anxiety will moderate anxiety changes. This study will enrich existing research on attention bias modification treatment by shedding light into potential mechanisms of change and will examine ways to improve the efficacy of this intervention.

02

Conditions studied

  • Social Anxiety

Browse trials for

Keywords

  • attention bias
  • treatment predictors
03

In context

Anxiety Disorders

4,864 studies on the registry are indexed under Anxiety Disorders; 1,388 are open to participants now.

This study's enrollment of 140 is above the median of 80 across 4,170 interventional studies indexed under Anxiety Disorders.

Browse Anxiety Disorders studies →

Lead sponsor

University of Cyprus is the lead sponsor of 28 studies on the registry; 10 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  1. highly socially anxious students (based on self-report questionnaire)

Exclusion criteria

Exclusion Criteria:

  1. suicidal intent,
  2. substance abuse,
  3. primary diagnosis of post-traumatic stress disorder, obsessive-compulsive disorder,
  4. or past schizophrenia, bipolar disorder, organic mental disorder,
  5. any concurrent psychotherapy,
  6. changes in medication during the 12 weeks prior to study and
  7. CBT therapy 6 months before the beginning of treatment.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Investigator)
Enrollment
140 participants (actual)

Study arms

  • Experimental
    Training away from threat

    Experiment 1 and 2: In the intervention group -training away from threat-, in all angry-neutral faces presentation the probe is presented only after neutral face. Probe type (\< or \>) is not factorially counterbalanced but there is equal possibility of presentation for each of the following: angry-face location, probe location, or actor. Experiment 1: received 8 times (2 times per week for 4 weeks) Experiment 2: received 4 times (2 times for 2 weeks)

    Behavioral: Training away from threat

  • Experimental
    Training towards threat

    Only for Experiment 2: The second ABMT condition -training towards threat- is identical to the first one with the exception that in all angry-neutral face presentations the symbol is presented only after threat face. In addition, at the beginning of every session participants will be informed that a random number of participants will have to repeat their speech. They will also be informed that this instruction will be given right after the dot probe task completion. This will be done in order for the participants to maintain their state anxiety but repetition of the speech task will not actually happen at this stage. Experiment 2: received 4 times (2 times for 2 weeks)

    Behavioral: Training towards threat

  • Placebo comparator
    Placebo

    Experiment 1 and 2: In the placebo group, angry-face location, probe location and actor are fully counterbalanced with regards to their presentation. Experiment 1: received 8 times (2 times per week for 4 weeks) Experiment 2: received 4 times (2 times for 2 weeks)

    Behavioral: Placebo

Interventions

  • BehavioralTraining away from threat

    Dot-probe task: Pairs of stimuli, angry - neutral face or neutral - neutral faces of the same actor (20 different individuals;10 male, 10 female) are presented horizontally in the centre of the screen (160 trials; 120 angry-neutral and 40 neutral-neutral). Each trial begins with a fixation cross (500 ms), on which the participants are instructed to focus their gaze. After that a pair of faces follows which is presented on the screen for 500ms. After the faces presentation a small visual probe (\< or \>) appears at the same place of one of the two faces. Participants have to determine which symbol appeared by clicking right or left on the mouse as quickly as possible. The target probe remains on the screen until there is a response, which starts a new trial.

  • BehavioralTraining towards threat

    Dot-probe task: Pairs of stimuli, angry - neutral face or neutral - neutral faces of the same actor (20 different individuals;10 male, 10 female) are presented horizontally in the centre of the screen (160 trials; 120 angry-neutral and 40 neutral-neutral). Each trial begins with a fixation cross (500 ms), on which the participants are instructed to focus their gaze. After that a pair of faces follows which is presented on the screen for 500ms. After the faces presentation a small visual probe (\< or \>) appears at the same place of one of the two faces. Participants have to determine which symbol appeared by clicking right or left on the mouse as quickly as possible. The target probe remains on the screen until there is a response, which starts a new trial.

  • BehavioralPlacebo

    Dot-probe task: Pairs of stimuli, angry - neutral face or neutral - neutral faces of the same actor (20 different individuals;10 male, 10 female) are presented horizontally in the centre of the screen (160 trials; 120 angry-neutral and 40 neutral-neutral). Each trial begins with a fixation cross (500 ms), on which the participants are instructed to focus their gaze. After that a pair of faces follows which is presented on the screen for 500ms. After the faces presentation a small visual probe (\< or \>) appears at the same place of one of the two faces. Participants have to determine which symbol appeared by clicking right or left on the mouse as quickly as possible. The target probe remains on the screen until there is a response, which starts a new trial.

06

What researchers measure

Primary outcomes

  1. Social Anxiety levels

    Experiment 1 \& 2: self-reported questionnaires, with the primary one to be Social Phobia and Anxiety Inventory-23.

    Time frame: Pre-treatment (day 1)

  2. Social Anxiety changes

    Experiment 1 \& 2: Measured in self-reported questionnaires with the primary one to be Social Phobia and Anxiety Inventory-23.

    Time frame: Experiment 1: 4 weeks after the day 1, Experiment 2: 3 weeks after the day 1 (Post-treatment)

  3. Social Anxiety changes

    Only for experiment 1: Measured in self-reported questionnaires with the primary one to be Social Phobia and Anxiety Inventory-23.

    Time frame: 6 months after day 1 (Follow-up)

  4. Attentional Biases

    For experiment 1: Assess kind of attentional biases using the dot-probe task (comparison of reaction time to threatening and a neutral stimulus). For experiment 2: Assess kind of attentional biases using the eye-tracking task (measuring eye gaze).

    Time frame: Pre-treatment (day 1)

  5. Attentional Biases changes

    For experiment 1: Assess kind of attentional biases using the dot-probe task (comparison of reaction time to threatening and a neutral stimulus). For experiment 2: Assess kind of attentional biases using the eye-tracking task (measuring eye gaze).

    Time frame: 4 weeks after the day 1 (Post-treatment)

  6. Attentional Biases changes

    Only for experiment 1: Assess kind of attentional biases using the dot-probe task (comparison of reaction time to threatening and a neutral stimulus).

    Time frame: 6 months after day 1 (Follow-up)

  7. Physical social anxiety levels

    Only for experiment 2: measured through physiological measures, with the primary one to be heart rate.

    Time frame: Pre-treatment (day 1)

  8. Physical social anxiety changes

    Only for experiment 2: measured through physiological measures, with the primary one to be heart rate.

    Time frame: 3 weeks after the day 1 (Post-treatment)

Secondary outcomes

  1. Social Anxiety levels (clinical interview)

    Experiment 1 \& 2: measured through clinical interview, Anxiety Disorders Interview Schedule (ADIS) adult version.

    Time frame: Pre-treatment (day 1)

  2. Physical social anxiety levels 1

    Only for experiment 2: measured through skin conductance

    Time frame: Pre-treatment (day 1)

  3. Physical social anxiety levels 2

    Only for experiment 2: measured through corrugator supercilii

    Time frame: Pre-treatment (day 1)

  4. Social anxiety changes

    Experiment 1: measured through clinical interview, Anxiety Disorders Interview Schedule (ADIS) adult version.

    Time frame: 4 weeks after the day 1 (Post-treatment)

  5. Physical social anxiety changes 1

    Only for experiment 2: measured through skin conductance

    Time frame: 3 weeks after the day 1 (Post-treatment)

  6. Social anxiety changes

    Experiment 1: measured through clinical interview, Anxiety Disorders Interview Schedule (ADIS) adult version.

    Time frame: 6 months after day 1 (follow-up)

  7. Physical social anxiety changes 2

    Only for experiment 2: measured through corrugator supercilii

    Time frame: 3 weeks after the day 1 (Post-treatment)

07

Study locations

1 site
  • Department of Psychology, University of Cyprus
    Nicosia, 1678, Cyprus
08

References and documents

Publications

  • Amir N, Beard C, Taylor CT, Klumpp H, Elias J, Burns M, Chen X. Attention training in individuals with generalized social phobia: A randomized controlled trial. J Consult Clin Psychol. 2009 Oct;77(5):961-973. doi: 10.1037/a0016685. PubMed 19803575 ↗
  • Bar-Haim Y. Research review: Attention bias modification (ABM): a novel treatment for anxiety disorders. J Child Psychol Psychiatry. 2010 Aug;51(8):859-70. doi: 10.1111/j.1469-7610.2010.02251.x. Epub 2010 May 6. PubMed 20456540 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 30, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03601377
Lead sponsor
University of Cyprus
Collaborators
Youth Board of Cyprus, Tel Aviv University
Responsible party
Klavdia Neophytou (PhD Clinical Psychology Student, University of Cyprus) — Principal investigator
First posted
Jul 26, 2018
Start date
Oct 3, 2016
Primary completion
Jul 31, 2018
Completion
Sep 30, 2018
Last update
Oct 30, 2018

Study contacts

Georgia Panayiotou, PhD
study director · Associate Prof., Department of Psychology, University of Cyprus

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion